<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04381455</url>
  </required_header>
  <id_info>
    <org_study_id>DD-01</org_study_id>
    <nct_id>NCT04381455</nct_id>
  </id_info>
  <brief_title>Evaluation of OSSIX® Bone in Sinus Elevation</brief_title>
  <official_title>Evaluation of OSSIX® Bone in Maxillary Sinus Floor Augmentation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Studio Odontoiatrico Associato Dr. P. Cicchese e L. Canullo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Studio Odontoiatrico Associato Dr. P. Cicchese e L. Canullo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A post marketing observational study to evaluate clinical performance of OSSIX Bone in&#xD;
      maxillary sinus elevation procedure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 4, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in Bone height from baseline</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in bone volume</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Maxillary Sinus Floor Augmentation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OSSIX Bone</intervention_name>
    <description>subjects will be implanted with OSSIX Bone during sinus elevation surgery</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that need sinus elevation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient requiring vertical elevation of the maxillary sinus.&#xD;
&#xD;
          2. Residual alveolar bone height of edentulous maxilla below the floor of the maxillary&#xD;
             sinus of &gt; 4-5mm.&#xD;
&#xD;
          3. Males and females between 30-80 years old&#xD;
&#xD;
          4. Patients with healthy periodontal conditions (Treated periodontitis, PI&lt;25%, BoP&lt;25%)&#xD;
&#xD;
          5. Patients that are willing to sign an informed consent and participate in a clinical&#xD;
             study&#xD;
&#xD;
          6. Generally fit and healthy and able to undergo oral surgical procedures under local&#xD;
             anesthesia.&#xD;
&#xD;
          7. Teeth at the surgical site which required removal were extracted a minimum of 12 weeks&#xD;
             prior to sinus floor elevation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who smoke over 5 cigarettes/day&#xD;
&#xD;
          2. Pregnancy (confirmed by verbal inquiry)&#xD;
&#xD;
          3. Chronic systemic pathologies (e.g. diabetes) and neoplastic of the Oro-Facial District&#xD;
             4.&#xD;
&#xD;
          4. Patients taking bisphosphonates&#xD;
&#xD;
          5. Any sites where an implant already failed sites&#xD;
&#xD;
          6. Untreated Periodontitis&#xD;
&#xD;
          7. Dental sites with acute infections&#xD;
&#xD;
          8. Chronic inflammatory diseases of the oral cavity&#xD;
&#xD;
          9. Autoimmune diseases (cortisone intake)&#xD;
&#xD;
         10. Allergy declared to one or more medicaments to be used during treatment&#xD;
&#xD;
         11. Alcoholics patients and/or drug addicts&#xD;
&#xD;
         12. Patients with known collagen hypersensitivity.&#xD;
&#xD;
         13. Patients with sensitivity to porcine-derived materials.&#xD;
&#xD;
         14. History or malignant tumours of the maxillary sinus&#xD;
&#xD;
         15. History of local radiation therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luigi Canullo, DDS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Study site</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Studio Odont.Associato Dr.P.Cicchese E L.Canullo</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>May 7, 2020</study_first_submitted>
  <study_first_submitted_qc>May 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2020</study_first_posted>
  <last_update_submitted>February 10, 2021</last_update_submitted>
  <last_update_submitted_qc>February 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Studio Odontoiatrico Associato Dr. P. Cicchese e L. Canullo</investigator_affiliation>
    <investigator_full_name>Luigi Canullo</investigator_full_name>
    <investigator_title>Dr Luigi Canullo, DDS, Ph.D</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

